IQVIA United States reposted this
IQVIA Institute just released a report on the CMS Prescription Drug Negotiations, examining the impact of the Inflation Reduction Act (IRA) on Medicare prescription drug prices. One of the IRA’s primary goals is to improve Medicare affordability and accessibility, but the actual savings for beneficiaries may be limited. The report highlights key provisions such as the $2,000 annual cap on out-of-pocket costs and insulin priced at $35/month. It also explores the newly introduced federal negotiations with drug manufacturers, aimed at reducing the cost of high-expenditure brand-name drugs under Medicare Part B and Part D. However, the analysis shows that government price negotiations may not consistently reduce patient cost sharing, with many Medicare enrollees seeing little to no financial benefit. Our report is essential for anyone following the evolving landscape of Medicare. https://bit.ly/3zJdWJR #Medicare #PharmaSpending #HealthcarePolicy